Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom-Reference-Cited by-同舟云学术

Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom

Published:2021-05-27 Issue:4 Volume:8 Page:3049-3057
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Schueler Stephan¹^ORCID,Silvestry Scott C.²^ORCID,Cotts William G.³,Slaughter Mark S.⁴,Levy Wayne C.⁵^ORCID,Cheng Richard K.⁵^ORCID,Beckman Jennifer A.⁵,Villinger Jonas⁶^ORCID,Ismyrloglou Eleni⁷,Tsintzos Stelios I.⁶^ORCID,Mahr Claudius⁵^ORCID

Affiliation:

1. Cardiothoracic Surgery Freeman Hospital Newcastle UK

2. Cardiothoracic Surgery Advent Health Transplant Institute Orlando FL USA

3. Heart Transplantation and Mechanical Assistance Advocate Christ Medical Center Oak Lawn IL USA

4. Cardiovascular and Thoracic Surgery University of Louisville Louisville KY USA

5. Cardiology University of Washington Seattle WA USA

6. Medtronic International Trading Sarl Tolochenaz Switzerland

7. Medtronic Bakken Research Center B.V. Maastricht The Netherlands

Funder

Medtronic

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13401

Reference40 articles.

1. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals

2. Clinical effectiveness and cost‐effectiveness of second‐and third‐generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost‐effectiveness model;Sutcliffe P;Health Technol Assess (Winch Eng),2013

3. The year in cardiology 2018: heart failure

4. McDonaghT ClarkA MindhamR deBelderM ShateA AjayiS SingarayerS.National Heart Failure Audit (NHFA): 2020 Summary Report (2018/19 Data). In:HQIP;2020.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Left ventricular assist devices for treatment of refractory advanced heart failure: the Western Australian experience;Internal Medicine Journal;2023-08-24

2. Editorial: Health technology assessment in cardiovascular diseases;Frontiers in Cardiovascular Medicine;2023-01-24

3. Ex-vivo lung perfusion therapies: do they add value to organ donation?;Current Opinion in Organ Transplantation;2022-06

4. A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective;The Journal of Heart and Lung Transplantation;2022-02